Literature DB >> 8825338

Multiple 5-HT receptors in the guinea-pig superior cervical ganglion.

C J Watkins1, N R Newberry.   

Abstract

1. We have studied the pharmacology of the depolarization by 5-hydroxytryptamine (5-HT) of the guinea-pig isolated superior cervical ganglion (SCG) using the grease-gap technique. We studied the effects of selective and non-selective antagonists on the responses to 5-HT and other 5-HT receptor agonists. 2. We have extended the pharmacology of the 5-HT3 receptor in this preparation by studying the effects of granisetron, BRL 46470 and mianserin on the concentration-response curve (CRC) to 2-methyl-5-HT. As with other 5-HT3 receptor antagonists, these compounds exhibited a lower affinity for guinea-pig 5-HT3 receptors than for rat 5-HT3 receptors. 3. We have confirmed that low concentrations of 5-HT (< or = 1 microM) mediate ketanserin-sensitive responses and higher concentrations of 5-HT also recruit 5-HT3 receptors. The responses to low concentrations of 5-HT were antagonized by low concentrations of ketanserin, spiperone, mianserin, DOI and LSD indicating probably mediation by 5-HT2A receptors. At high concentrations, the hallucinogen, DOI, but not LSD, evoked a ketanserin-sensitive depolarization. 4. Although mianserin could bind to the 5-HT2A receptors in this preparation, we could not demonstrate a down-regulation of depolarizations evoked by these receptors after a 10 day oral treatment with mianserin (10 mg kg-1, daily). 5. 5-Carboxamidotryptamine (5-CT) evoked a prolonged depolarization. Although high concentrations of 5-CT (> or = microM) appeared to activate 5-HT2A receptors, lower concentrations of 5-CT evoked a response with a distinct pharmacology. After studying the action of 20 selective and non-selective 5-HT receptor ligands we believe that this response may be mediated by a novel receptor; but its pharmacology is closest to that of receptors in the 5-HT2 receptor family. Like 5-CT, 5-HT (3-300 microM) could evoke an LSD-sensitive response in the presence of the 5-HT2 receptor antagonist, ketanserin and the 5-HT3 receptor antagonist, tropisetron (all 1 microM). 6. We conclude that 5-HT activates three pharmacologically distinct receptors to depolarize the guinea-pig SCG. Low concentrations of 5-HT appear to activate 5-HT2A receptors. Higher concentrations of 5-HT also activate 5-HT3 receptors and a possible novel 5-HT receptor. The novel receptor could be a species homologue of a 5-HT2 receptor or an, as yet, unclassified 5-HT receptor.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8825338      PMCID: PMC1909384          DOI: 10.1111/j.1476-5381.1996.tb15149.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  42 in total

1.  The action of 5-hydroxytryptamine on the nictitating membrane and on the superior cervical ganglion of the cat.

Authors:  U TRENDELENBURG
Journal:  Br J Pharmacol Chemother       Date:  1956-03

Review 2.  5-HT2 receptor subtypes: a family re-united?

Authors:  G Baxter; G Kennett; F Blaney; T Blackburn
Journal:  Trends Pharmacol Sci       Date:  1995-03       Impact factor: 14.819

Review 3.  Molecular biology of 5-HT receptors.

Authors:  F G Boess; I L Martin
Journal:  Neuropharmacology       Date:  1994 Mar-Apr       Impact factor: 5.250

4.  Ionic mechanisms and receptor properties underlying the responses of molluscan neurones to 5-hydroxytryptamine.

Authors:  H M Gerschenfeld; D Paupardin-Tritsch
Journal:  J Physiol       Date:  1974-12       Impact factor: 5.182

Review 5.  International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (Serotonin).

Authors:  D Hoyer; D E Clarke; J R Fozard; P R Hartig; G R Martin; E J Mylecharane; P R Saxena; P P Humphrey
Journal:  Pharmacol Rev       Date:  1994-06       Impact factor: 25.468

6.  BRL 46470A: a highly potent, selective and long acting 5-HT3 receptor antagonist with anxiolytic-like properties.

Authors:  T P Blackburn; G S Baxter; G A Kennett; F D King; D C Piper; G J Sanger; D R Thomas; N Upton; M D Wood
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

7.  5-HT1D as well as 5-HT1A autoreceptors modulate 5-HT release in the guinea-pig dorsal raphé nucleus.

Authors:  S J Starkey; M Skingle
Journal:  Neuropharmacology       Date:  1994 Mar-Apr       Impact factor: 5.250

8.  Cloning and expression of a 5-hydroxytryptamine7 receptor positively coupled to adenylyl cyclase.

Authors:  A P Tsou; A Kosaka; C Bach; P Zuppan; C Yee; L Tom; R Alvarez; S Ramsey; D W Bonhaus; E Stefanich
Journal:  J Neurochem       Date:  1994-08       Impact factor: 5.372

9.  Antagonist-mediated down-regulation of 5-hydroxytryptamine type 2 receptor gene expression: modulation of transcription.

Authors:  M Toth; T Shenk
Journal:  Mol Pharmacol       Date:  1994-06       Impact factor: 4.436

10.  Evidence that the 5-HT3 receptors of the rat, mouse and guinea-pig superior cervical ganglion may be different.

Authors:  N R Newberry; S H Cheshire; M J Gilbert
Journal:  Br J Pharmacol       Date:  1991-03       Impact factor: 8.739

View more
  2 in total

Review 1.  Serotonin and blood pressure regulation.

Authors:  Stephanie W Watts; Shaun F Morrison; Robert Patrick Davis; Susan M Barman
Journal:  Pharmacol Rev       Date:  2012-03-08       Impact factor: 25.468

2.  5-Hydroxytryptamine does not reduce sympathetic nerve activity or neuroeffector function in the splanchnic circulation.

Authors:  Emma S Darios; Susan M Barman; Hakan S Orer; Shaun F Morrison; Robert P Davis; Bridget M Seitz; Robert Burnett; Stephanie W Watts
Journal:  Eur J Pharmacol       Date:  2015-02-28       Impact factor: 4.432

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.